| Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia A Ferrajoli, TD Shanafelt, C Ivan, M Shimizu, KG Rabe, N Nouraee, ... Blood, The Journal of the American Society of Hematology 122 (11), 1891-1899, 2013 | 246 | 2013 |
| Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma N Nouraee, K Van Roosbroeck, M Vasei, S Semnani, NM Samaei, ... PloS one 8 (9), e73009, 2013 | 116 | 2013 |
| miRNA therapeutics in cardiovascular diseases: promises and problems N Nouraee, SJ Mowla Frontiers in Genetics 6, 140171, 2015 | 103 | 2015 |
| Downregulation of plasma MiR-142-3p and MiR-26a-5p in patients with colorectal carcinoma R Ghanbari, N Mosakhani, J Asadi, N Nouraee, SJ Mowla, Y Yazdani, ... Iranian journal of cancer prevention 8 (3), 2015 | 62 | 2015 |
| Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids MA Javidi, AH Ahmadi, B Bakhshinejad, N Nouraee, S Babashah, ... Medical oncology 31, 1-11, 2014 | 59 | 2014 |
| Simultaneous underexpression of let-7a-5p and let-7f-5p microRNAs in plasma and stool samples from early stage colorectal carcinoma: supplementary issue: biomarkers for colon … R Ghanbari, N Mosakhani, VK Sarhadi, G Armengol, N Nouraee, ... Biomarkers in cancer 7, BIC. S25252, 2015 | 58 | 2015 |
| Epstein–Barr virus microRNAs are expressed in patients with chronic lymphocytic leukemia and correlate with overall survival A Ferrajoli, C Ivan, M Ciccone, M Shimizu, Y Kita, M Ohtsuka, L D'Abundo, ... EBioMedicine 2 (6), 572-582, 2015 | 55 | 2015 |
| Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer N Hatefi, N Nouraee, M Parvin, SAM Ziaee, SJ Mowla Iranian journal of basic medical sciences 15 (6), 1154, 2012 | 48 | 2012 |
| Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer R Ghanbari, N Mosakhani, J Asadi, N Nouraee, SJ Mowla, H Poustchi, ... Cancer biomarkers 15 (2), 189-195, 2015 | 40 | 2015 |
| MicroRNAs contribution in tumor microenvironment of esophageal cancer N Nouraee, S Khazaei, M Vasei, SF Razavipour, M Sadeghizadeh, ... Cancer Biomarkers 16 (3), 367-376, 2016 | 36 | 2016 |
| A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression S Khazaei, N Nouraee, A Moradi, SJ Mowla Clinical and Translational Oncology 19, 633-640, 2017 | 35 | 2017 |
| Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker N NOURAEI, SJ MOULA, A OUZHAND, M Parvin, SAM ZIAEI, N Hatefi UROLOGY JOURNAL 6 (2), 101-108, 2009 | 35 | 2009 |
| Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells JA Rath, G Bajwa, B Carreres, E Hoyer, I Gruber, MA Martínez-Paniagua, ... Science advances 6 (27), eaaz7809, 2020 | 30 | 2020 |
| OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers PC Monroig-Bosque, MY Shah, X Fu, E Fuentes-Mattei, H Ling, C Ivan, ... Scientific reports 8 (1), 13106, 2018 | 28 | 2018 |
| Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma M Tabrizi, M Khalili, M Vasei, N Nouraei, NM Samaei, A Khavanin, ... Archives of Iranian medicine 18 (3), 0-0, 2015 | 23 | 2015 |
| MicroRNAs as cancer biomarkers GAC Nazila Nouraee microRNA 2 (2), 102-117, 2013 | 16 | 2013 |
| Tracking miRNAs' footprints in tumor–microenvironment interactions: insights and implications for targeted cancer therapy N Nouraee, SJ Mowla, GA Calin Genes, Chromosomes and Cancer 54 (6), 335-352, 2015 | 15 | 2015 |
| A costimulatory CAR improves TCR-based cancer immunotherapy B Omer, MG Cardenas, T Pfeiffer, R Daum, M Huynh, S Sharma, ... Cancer immunology research 10 (4), 512-524, 2022 | 14 | 2022 |
| Separation of microRNA 21 as a cancer marker from glioblastoma cell line using molecularly imprinted polymer coated on silica nanoparticles H Hashemi‐Moghaddam, M Kashi, SJ Mowla, N Nouraee Journal of separation science 39 (18), 3564-3570, 2016 | 13 | 2016 |
| CD30. CAR-modified Epstein-Barr virus-specific T cells (CD30. CAR EBVSTs) provide a safe and effective off-the-shelf therapy for patients with CD30-positive lymphoma DH Quach, CA Ramos, PD Lulla, S Sharma, HR Ganesh, N Nouraee, ... Blood 140 (Supplement 1), 412-414, 2022 | 9 | 2022 |
